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Background-—Diagnosis of short QT syndrome (SQTS) remains difficult in case of borderline QT values as often found in normal
populations. Whether some shortening of refractory periods (RP) may help in differentiating SQTS from normal subjects is
unknown.
Methods and Results-—Atrial and right ventricular RP at the apex and right ventricular outflow tract as determined during standard
electrophysiological study were compared between 16 SQTS patients (QTc 32424 ms) and 15 controls with similar clinical
characteristics (QTc 41732 ms). Atrial RP were significantly shorter in SQTS compared with controls at 600- and 500-ms basic
cycle lengths. Baseline ventricular RP were significantly shorter in SQTS patients than in controls, both at the apex and right
ventricular outflow tract and for any cycle length. Differences remained significant for RP of any subsequent extrastimulus at any
cycle length and any pacing site. A cut-off value of baseline RP <200 ms at the right ventricular outflow tract either at 600- or 500-
ms cycle length had a sensitivity of 86% and a specificity of 100% for the diagnosis of SQTS.
Conclusions-—Patients with SQTS have shorter ventricular RP than controls, both at baseline during various cycle lengths and after
premature extrastimuli. A cut-off value of 200 ms at the right ventricular outflow tract during 600- and 500-ms basic cycle length
may help in detecting true SQTS from normal subjects with borderline QT values. ( J Am Heart Assoc. 2017;6:e005684. DOI: 10.
1161/JAHA.117.005684.)
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S hort QT syndrome (SQTS) is an inherited channelopathyinitially described in 20001 associating a short QT
interval to ventricular and atrial arrhythmias and carrying a
risk of sudden cardiac death (SD).2,3 It is a very exceptional
syndrome with only some tens of cases reported in the
literature so far.4,5
Even if apparently straightforward because simply linked to
the value of QT interval, diagnosis of SQTS has in fact
remained poorly defined over previous years because of
changing cut-off values.6 A diagnostic value of 300 ms,1,7
then of 320 ms8 for the QT interval and of 340 ms for the
corrected QT (QTc)9 had been initially proposed, although
some symptomatic patients with SQTS may present with
longer QTc interval.4,10–12 A diagnostic score was proposed in
2011, including QTc value, and clinical and family history,
demonstrating excellent sensitivity,4 although this score has
not gained wide acceptance because of some limitations.13,14
SQTS should be currently diagnosed in the presence of a QTc
≤330 to 360 ms according to recent guidelines.2,3
SQTS diagnosis is furthermore complicated by an overlap-
ping range of QT values between healthy subjects and
affected cases. Epidemiological studies of control populations
showed that a QT interval <320 to 340 ms was not
associated with a higher risk of SD over very long-term
follow-up.15,16 That is why additional clinical parameters are
currently needed for diagnosing SQTS.2,3
However, borderline QTc values may lead to overdiagnosis
of SQTS in the general population, especially in case of
symptoms or familial SD of undetermined origin, while
overestimation of corrected QT at high rates using standard
corrective formulas14 may lead to underdiagnosis of true
SQTS. Moreover, reliability of QT interval measurement is far
from perfect in clinical practice.17 Thus, a more reliable
repolarization parameter, with less inter/intraobserver vari-
ability and less dependence on the heart rate—or showing
different rate dependence—would be very useful for SQTS
diagnosis. Earlier works had shown some shortening of
ventricular and atrial refractory periods (RP) in patients with
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SQTS.7,18 Even if short ventricular RP are common in SQTS,
their additional shortening after short cycle lengths has not
been evaluated. A greater than normal shortening of repolar-
ization in SQTS may help in detecting borderline forms of
SQT.
The aim of the study was to compare RP and their
shortening at short cycle lengths between patients with SQTS
and controls using standard programmed stimulation during
electrophysiological study.
Methods
Study Population
Between 2005 and 2015, 16 successive patients with SQTS
(14 men, 2410 years old) coming from 8 unrelated families
(median 1/family) have been investigated, while 15 subjects
without SQTS (11 men, 2714 years old) prospectively
included serve as the control group.
Diagnosis of SQTS was made according to the current
guidelines2,3: each patient had a history of QTc interval
shorter than 340 or <360 ms in association with resuscitated
SD, and/or a family history of SD <40 years old and/or of
familial SQTS.
Controls were subjects without any heart disease or
cardioactive drug, who have been invasively investigated at
our center for ablation of supraventricular tachycardia (retro-
grade accessory pathway n=8, atrioventricular node re-
entrant tachycardia n=2) or investigation of noncardiac
syncope (n=2), palpitations (n=1), and idiopathic premature
ventricular beats (n=2).
Electrophysiological Study
The study was approved by our institutional review committee
and subjects gave informed consent.
Patients and controls were studied in the fasting state,
under mild sedation and off drugs. QT intervals were
measured using calipers on screen (50 mm/s speed) at the
beginning of the procedure. Corrected QT were calculated
using the Bazett formula. Standard quadripolar electrode
catheters (2-mm electrodes, 10-mm interelectrode spacing)
were inserted after femoral venous puncture. Programmed
ventricular stimulation was performed at the right ventricular
apex (RVA) and right ventricular outflow tract (RVOT), at 2-ms
duration and twice the pacing threshold.
Baseline RVA and RVOT RP were measured by scanning the
diastole using the S2 extrastimulus, with decreasing coupling
interval in 10-ms decrements until refractoriness (coupling
interval <200 ms allowed), during a drive of 8 S1 beats at 600-,
500-, and 400-ms cycle lengths. RP was defined by the longest
S2 coupling interval not achieving ventricular capture. Short-
ening of RP was evaluated by measuring the RP after S2 and S3
paced events at each pacing site and at each basic drive, using
the same method by adding S3 and S4 extrastimuli, respec-
tively. Coupling intervals of the tested S2 or S3 beats were set
20 ms over the RP of S1 and S2, respectively (Figure 1).
Atrial RP were determined using programmed stimulation
performed at the right lateral atrium at 2-ms duration and
twice the pacing threshold. Only baseline RP were determined
during pacing at 600-, 500-, and 400-ms cycle length.
AH, HV intervals were noted, as well as Wenckebach
conduction cycle length during fast atrial pacing, and RP of
the atrioventricular node was evaluated during atrial pro-
grammed stimulation at the 600-ms basic drive.
Statistical Analysis
Continuous data are expressed as meanstandard deviation
(or median and range in case of nongaussian distribution of
Figure 1. Protocol of programmed ventricular stimulation used
for the determination of refractory periods (RP). S indicates
stimulus.
Clinical Perspective
What Is New?
• SQTS patients display clearly shorter ventricular refractory
periods compared with controls.
What Are the Clinical Implications?
• Because the diagnosis of SQTS may be difficult in borderline
cases, evaluation of ventricular refractory periods during
standard electrophysiological study may be useful.
• A cut-off value of 200 ms at the right ventricular outflow
tract for 600- or 500-ms basic pacing rate differentiates
patients from normal subjects with excellent predictive
value.
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values). Continuous variables were compared using unpaired t
test or nonparametric Mann–Whitney test, as suitable.
Correlations between RP and QT intervals were evaluated
using Spearman rank correlation test. Analysis and calcula-
tions were performed using StatView™ program 1992–1996,
version 5.0 (Abacus Concepts, Inc, Berkeley, CA). A P<0.05
was considered statistically significant for each analysis.
Results
Population Characteristics
Clinical characteristics of SQTS patients and controls are
shown in Table 1. Nine SQTS patients were symptomatic
including cardiac arrest (n=2), syncope (n=4), or palpitations
(n=3). Eleven had a family history of SD. One had a history of
atrial fibrillation. Genetic screening was performed in all but
without finding mutations in anyone. Three patients with SQTS
received an implantable cardioverter defibrillator. None of the
patients with SQTS or control subjects had any heart disease,
cardioactive drug, or relevant comorbidity potentially linked to
changes in myocardial electrical parameters.
Patients with SQTS and control subjects had similar
cardiac rates before programmed stimulation (7010 bpm
versus 6711 bpm, P=ns). QT interval (30829 ms versus
39736 ms, P=0.0007) and QTc interval (32424 ms versus
41732 ms, P<0.0001) were significantly shorter in patients
with SQTS versus controls.
Electrophysiological study
Median pacing thresholds were 0.5 V at the right atrium, 0.5
at RV apex, and 1 V at RVOT without significant difference
between patients with SQTS and controls.
None of the following significantly differed between SQTS
patients and controls, respectively: AH interval (8854 ms
versus 8833 ms), HV interval (444 ms versus
4210 ms), atrioventricular node RP (30874 ms versus
30451 ms), or Wenckebach cycle length (390102 ms
versus 35051 ms).
Atrial RP were shorter in SQTS compared with controls at
600-, 500-, and 400-ms basic cycle lengths with differences
being significant for 600- and 500-ms cycle length (Table 2
and Figure 2). Sustained atrial fibrillation was induced by
atrial programmed stimulation in 8 patients with SQTS and in
only 1 control (P=0.008).
Baseline ventricular RP were consistently significantly
shorter in patients with SQTS than in controls, both at the
RVA and RVOT (Table 2 and Figure 3). For example, at 600-
ms cycle length, baseline RP were 18118 ms versus
23629 ms at the RVA and 18019 ms versus
23625 ms at RVOT (P<0.0001 for both). The differences
remained significant for RP of the S2 and S3 extrastimuli at
any cycle length and any pacing site (Table 3 and Figure 4).
Interestingly, there was also some paradoxical increase in
ventricular RP for the S3 extrastimulus compared with the
previous one (Figure 4), which was not seen in controls. An
example of very short RP after S2 stimulus in a patient with
SQTS is shown in Figure 5.
Shortening of ventricular RP (magnitude of decrease
between 600- and 400-ms baseline RP and magnitude of
decrease between S1 and S3 beats RP) was constantly lower
in patients with SQTS versus controls for each comparison but
without reaching statistical significance (Table 4 and Fig-
ure 6). Ventricular fibrillation was induced by programmed
ventricular stimulation in 6 patients with SQTS and in none of
the control subjects (P=0.008): ventricular fibrillation was
induced with 2 extrastimuli in 2 patients (150- and 190-ms
coupling interval for the last stimulus), with 3 extrastimuli in 3
(150, 160, and 160 ms for the last stimulus) (all but 1 at the
RVA), and was induced by incidental catheter manipulation
in 1).
Table 1. Clinical Characteristics of Patients With SQTS and
Control Subjects
SQTS (n=16) Controls (n=15) P Value
Age 2410 2714 ns
Sex 14 men 11 men ns
Height, cm 1797 1767 ns
Weight, kg 7312 7514 ns
BMI, kg/m2 233 245 ns
Hypertension 1 0 ns
Diabetes mellitus 1 0 ns
BMI indicates body mass index; ns, non significant; SQTS, short QT syndrome.
Table 2. Baseline Refractory Periods in SQTS and Controls
for Atrium, RV Apex, and RVOT
SQTS (ms) Controls (ms) P Value
Atrial RP (600 ms) 17727 24565 0.002
Atrial RP (500 ms) 19314 22739 0.04
Atrial RP (400 ms) 19724 22040 0.2
RVA RP (600 ms) 18118 23629 <0.0001
RVA RP (500 ms) 17217 22633 <0.0001
RVA RP (400 ms) 16714 21326 <0.0001
RVOT RP (600 ms) 18019 23625 <0.0001
RVOT RP (500 ms) 17219 23122 <0.0001
RVOT RP (400 ms) 17416 21724 <0.0001
RP indicates refractory periods; RVA, right ventricular apex; RVOT, right ventricular
outflow tract; SQTS, short QT syndrome.
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A cut-off value of baseline RP <200 ms at the RVOT (either
at 600- or 500-ms cycle length) had a sensitivity of 86% and a
specificity of 100% for the diagnosis of SQTS (negative
predictive value 88% and positive predictive value 100%)
(Figure 7).
Testing this cut-off value in 10 other additional patients
with SQTS (6 men, 4715 years old, QT 28122 ms, QTc
30417 ms) and in 20 other additional controls (16 men,
5522 years old, QT 41841 ms, QTc 42237 ms) demon-
strated that 9 of 10 patients with SQTS had RVOT RP
<200 ms (mean 17028 ms) and that 20 of 20 controls had
RP >200 ms (mean 25021 ms).
There was no significant correlation between baseline
atrial/ventricular RP and clinical parameters or induction of
atrial fibrillation or ventricular fibrillation in patients with
SQTS, although RP were found to be shorter in inducible
cases. Baseline ventricular RP were shorter at each cycle
length in patients with familial SD, but this was significant for
RVA only (data not shown). Baseline ventricular RPs were
positively correlated to QT intervals (P<0.05).
Discussion
SQTS should be currently diagnosed in the presence of a QTc
≤330 to 340 ms or of a QTc ≤360 ms together with clinical
features according to recent guidelines.2,3 However, diagnosis
of SQTS may be challenging when QTc are of borderline
values, and some patients with true SQTS may have longer
QTc duration.4,10–12 Moreover, there is a large overlapping
between healthy subjects and SQTS, which is illustrated by
long-term follow-up population-based studies showing no
adverse prognosis among subjects with a QTc <300 to
360 ms.15,16,19 This suggests that the QT interval value alone
is not sufficient to identify patients with SQTS. Based on these
findings, recent guidelines proposed that diagnosis of SQTS
might be done only when additional clinical parameters are
present.2,3
Additional ECG markers have also been proposed to
identify true SQTS among patients with borderline QT interval,
such as a virtual ST segment,9,20 symmetrical and narrow T
waves,9 PQ segment depression,11, or decrease of QT during
exercise.21 These abnormalities could be helpful to identify
SQTS among patients with borderline QT interval. However,
the presence of borderline forms still remains an issue,
carrying the risk of under- and overdiagnosis. Thus, a more
robust repolarization parameter, with better measurement
reliability, less inter/intraobserver variability, and less inter-
dependence with the heart rate than QT duration, or showing
Figure 2. Atrial refractory periods at 600-, 500-,
and 400-ms cycle lengths in SQTS (light gray) and
controls (shaded). *indicates statistically significant
difference; SQTS, short QT syndrome.
Figure 3. Right ventricular refractory periods at the right
ventricular apex (RV apex) and right ventricular outflow tract
(RVOT) at 600-, 500-, and 400-ms cycle lengths in SQTS (light
gray) and controls (shaded) *indicates statistically significant
difference; SQTS, short QT syndrome.
Table 3. Refractory Periods in SQTS and Controls for
Premature Beats at RV Apex and RVOT
SQTS (ms) Controls (ms) P Value
S2 RP RVA (600 ms) 13317 18147 0.008
S3 RP RVA (600 ms) 13914 18142 0.01
S2 RP RVA (500 ms) 13515 18145 0.01
S3 RP RVA (500 ms) 13715 17930 0.001
S2 RP RVA (400 ms) 12413 16334 0.003
S3 RP RVA (400 ms) 14112 17923 0.0008
S2 RP RVOT (600 ms) 13916 19230 0.0003
S3 RP RVOT (600 ms) 14911 18533 0.01
S2 RP RVOT (500 ms) 13720 18929 0.0004
S3 RP RVOT (500 ms) 15012 19032 0.005
S2 RP RVOT (400 ms) 13314 18430 0.0002
S3 RP RVOT (400 ms) 15212 18225 0.01
RP indicates refractory periods; RVA, right ventricular apex; RVOT, right ventricular
outflow tract; SQTS, short QT syndrome.
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different rate dependence, would be very useful for SQTS
diagnosis.
In 2004, Gaita et al performed noninvasive programmed
ventricular stimulation through the implantable cardioverter
defibrillator of 5 implanted SQTS patients. Ventricular RP were
short (14513 ms) and prolonged after quinidine treatment
to 22022 ms.18 Ventricular RP had also been measured
during standard electrophysiological study in 2 of these
patients with SQTS and did not exceed 150 ms at any pacing
site or pacing cycle length.7 More recently, in the European
registry, 28 patients had undergone electrophysiological
study, and ventricular RP varied between 140 and 200 ms
(mean 16621) and were correlated to HERG mutations
(15114 with versus 17624 ms, P=0.01) but not to clinical
events.5 Normal values for baseline ventricular RP in control
populations are expected to be higher, previously evaluated to
25327 ms22 or 24521 ms.23 Demonstrating a significant
difference between SQTS and normal subjects and finding a
cut-off value clearly distinguishing patients from controls
would be of considerable value for diagnosis of patients with
SQTS with borderline QT intervals.
Figure 4. Right ventricular refractory periods for S2 and S3 extrastimuli at the right ventricular apex (RA apex) and right ventricular outflow
tract (RVOT) at 600-, 500-, and 400-ms cycle lengths in SQTS (light gray) and controls (shaded). *indicates statistically significant difference;
SQTS, short QT syndrome.
Figure 5. Example of very short ventricular refractory periods
(RP) after S2 stimulus in a patient with SQTS: after S2
extrastimulus, the S3 extrastimulus leads to ventricular capture
for a coupling interval as short as 130 ms before reaching local
RP at a coupling interval of 110 ms. S indicates stimulus; SQTS,
short QT syndrome.
Table 4. Decrease in Refractory Periods in SQTS and
Controls for RV Apex and RVOT
SQTS Controls P Value
Baseline 600 to 400 ms RVA* 1511 2324 0.2
Baseline 600 to 400 ms RVOT* 1111 1622 0.5
S3-S1 RVA 600 ms† 3910 5532 0.2
S3-S1 RVOT 600 ms† 3813 5523 0.1
S3-S1 RVA 500 ms† 3518 4928 0.2
S3-S1 RVOT 500 ms† 3014 4423 0.2
S3-S1 RVA 400 ms† 2913 3617 0.3
S3-S1 RVOT 400 ms† 2812 3623 0.4
RVA indicates right ventricular apex; RVOT, right ventricular outflow tract; SQTS, short QT
syndrome.
*Difference in S1 RP between 600 and 400 ms baseline cycle length.
†Difference between S1 and S3 RP.
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In the present study, we compared ventricular and atrial
refractory periods between patients with SQTS and controls
as retrieved during standard electrophysiological study.
Patients with SQTS showed shorter atrial RP than controls
for the slowest cycle lengths while demonstrating significantly
shorter right ventricular RP than controls, disregarding the
pacing site and cycle length, both at baseline and after 1 or 2
extrastimuli, sometimes displaying extremely short values.
These excessively shortened RP mean that right ventricular
myocardial cells are able to be reactivated sometimes less
Figure 6. Plot of ventricular refractory periods (RP) against S1, S2, and S3 beats, at the right ventricular
apex (RA apex) and right ventricular outflow tract (RVOT), at 600-, 500-, and 400-ms cycle lengths, both in
SQTS and controls, showing decrease in RP for shorter basic cycle length or for additional short-coupled
extrastimuli. SQTS indicates short QT syndrome.
Figure 7. Distribution of SQTS patients and controls according to a 200-ms cut-off value of baseline
ventricular refractory periods (RP) at the right ventricular outflow tract (RVOT) at 600- or 500-ms cycle
length. None of the controls showed RP <200 ms while almost none of the SQTS displayed RP >200 ms.
SQTS indicates short QT syndrome.
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than 130 ms after the preceding activation. This could be the
consequence of very fast repolarization because of the
mutated ionic currents involved, especially after previous
short cycle lengths, which are known to physiologically
decrease refractoriness in myocardial tissues.22,24
The magnitude of decrease of RP (either between different
pacing rates or between the first and third extrastimuli) even if
lower in patients with SQTS, was, however, not significantly
different from controls, indicating that the mechanisms
controlling the decrease of RP after short cycle lengths are
not significantly altered in patients with SQTS, in opposition to
the decrease in QT intervals, which seems blunted.21 Thus,
such decreased of RP remains possible even with shorter
baseline RP (no baseline minimal RP value leading to the lack
of further decrease seems to exist for the cycle lengths/
coupling intervals investigated here). However, we also
observe some paradoxical increase in ventricular RP for the
S3 extrastimulus compared with the previous one, which was
not seen in controls. Maybe some “fatigue” or blunting in
refractoriness may alter the normal physiological repolarizing
processes in patients with SQTS. This also may lead to some
arrhythmogenicity.
Moreover, we found that a baseline ventricular RP cut-off
value of <200 ms at the RVOT during 600- or 500-ms cycle
length pacing yielded excellent predictive values for the
diagnosis of SQTS: all but 2 patients with SQTS displayed RP
≥200 ms (200 ms in both cases), while no control demon-
strated shorter values. Even controls with the shortest QTc—
<400 ms—had RP >200 ms. This cut-off value may help in
the diagnosis of SQTS in patients with borderline QT values
with sufficient confidence. An additional higher decrease in RP
may also provide further help in diagnosing SQTS for patients
with borderline RP according to our data, even if no cut-off
value could be proposed.
Even if RF were found to be grossly correlated to the QT
intervals, RP are not a full surrogate for QT duration. Even for
the shortest QT durations in controls, RP remain always
higher compared with true SQT patients, and a 200 ms cut-off
value seems to reliably separate true SQT from normal
subjects even with relatively short QT duration. In the normal
subjects with the shortest QT (40% of our control population
had QTc between 360 and 400 ms), no RP was found to be
shorter than 200 ms, and conversely none of the borderline
QT (between 340 and 360 ms in one third of true SQTS cases)
had RP >200 ms.
Thus, based on these findings, we propose here a simple
diagnosis technique for differentiating SQTS from the general
population. Even if invasive, this would be useful for patients
with borderline QT presenting with syncope, for example, or
even for asymptomatic cases in order to avoid unnecessary
follow-up, although asymptomatic SQTS does not need any
special management according to the current guidelines.3
Measurement of RP offers the first objective technique for
SQTS diagnosis, since QT measurement has many drawbacks,
whereas measurement of RP is straightforward.
Arrhythmogenesis in SQTS has been attributed to
heterogeneous abbreviation of the action potential duration
among different cell types of the ventricular wall in a canine
ventricular-wedge model of SQTS.25 The relationship
between the shortening of the QT and ventricular arrhyth-
mias has also been studied in computer models of the
human ventricle carrying a HeRG mutation known to be
involved in SQTS.26 The authors reported that the mutation
accelerated the ventricular repolarization, shortened the AP
duration and the effective ventricular RP while increasing
electrical heterogeneity at some local areas, leading to
increased risk of re-entrant arrhythmia. Shortening of the RP
was associated with a reduction of the tissue size required
to sustain re-entrant circuits in both 2 and 3 dimensions.26
On the basis of these results, a shortening of ventricular RP
may be directly correlated to an increased risk of ventricular
arrhythmia in SQTS, although shorter RPs were not linked to
the induction of ventricular fibrillation nor to the outcome in
our study.
Conclusion
Patients with SQTS have shorter right ventricular RPs than
controls, both at baseline during various cycle lengths and
after premature extrastimuli. A cut-off value of 200 ms at the
RVOT during 600- and 500-ms basic cycle length may help in
detecting borderline forms of SQTS.
Disclosures
None.
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